EIT Higher Education Institutions (HEI) Initiative: This call for proposals allows higher education institutions and business partners across Europe to collaborate on innovative projects, transforming higher education institutions into hubs for innovation and entrepreneurship.

Under the canSERV Open Call researchers are welcome to apply to a portfolio of services offered by canSERV to address the research needs of the entire oncology developmental pipeline. 

Your research project

• Can vary from basic discovery science to translational science and translation into personalised oncology.
• Is expected to address at least one of the four strategic goals of the Cancer Mission (understanding of cancer; prevention and early detection; diagnosis and treatment; quality of life for patients and their families).

• HORIZON-HLTH-2024-DISEASE-13-01: Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)

• HORIZON-HLTH-2024-CARE-14-01: Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems

• HORIZON-HLTH-2024-DISEASE-12-01: European partnership for pandemic preparedness

EIT Health Flagship Call: Digital Transformation of Healthcare

EIT Health flagship call 2025: IPCEI Med4Cure: The ReIndustrialisation of Europe Flagship Call 2025. Thematic areas: 

• DIGITAL TOOLS: Databases, tools to facilitate the use of clinical data, predictive model, federated data, in silico tools, etc.
• PERSONALISED MEDICINE: Diagnostic and early diagnostic, tools to facilitate improvements on current practices, AMR monitoring, genetic diversity, etc.
• GREEN MANUFACTURING: Bioproduction tools, innovative production, digitalisation of production lines, etc.

• CR-g-24-37: Call for proposals to support integration of cancer images into the federated pan-European infrastructure to foster screening programmes
• CR-g-24-39: Call for proposals to increase health literacy for cancer prevention and care
• CR-g-24-43: Call for proposals on the development of social services for psychosocial support and rehabilitation for children and their families in paediatric oncology clinics in Member States and countries associated to the EU4Health Programme
• CR-g-24-45: Call for proposals on EU Network of Youth Cancer Survivors

• HORIZON-JU-IHI-2024-08-01-two-stage: A city-based approach to reducing cardiovascular mortality in Europe
• HORIZON-JU-IHI-2024-08-02-two-stage: Novel endpoints for osteoarthritis (OA) by applying big data analytics
• HORIZON-JU-IHI-2024-08-03-two-stage: Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation
• HORIZON-JU-IHI-2024-08-04-two-stage: Patient-centred clinical-study endpoints derived using digital health technologies

Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union. The aim of this study is to map the provision of healthcare to Adolescent and Young Adults (AYA) cancer patients and survivors in all EU Member States, Norway and Iceland. Based on the evidence collected, the study will document and analyse the major barriers and enabling factors for the design and provision of quality care before, during and after cancer treatment, but also highlight best practices and innovative approaches. Recommendations for future actions directed at EU Member States, Norway and Iceland will be developed by the contractor, with relevant strategies to improve the provision of targeted healthcare to AYA cancer patients and survivors.

Short applications: any time
Full applications: 3 October 2024

The Accelerator Challenges have been identified in areas where breakthrough technologies or game-changing innovations developed by start-ups or SMEs can have a major impact on EU objectives. In 2024, these objectives include a.o. the Health Emergency Response Authority (HERA).

The ERA-NET NEURON partner countries are issuing the EXCELLENT PAPER IN NEUROSCIENCE AWARD to recognize the remarkable and outstanding scientific publications by early-career researchers in the field of disease-related, translational, neurosciences. Sole First Author of original research articles published between January 1, 2023, and December 31, 2023, and affiliated with the call partner countries listed below are eligible to apply.

• HORIZON-HLTH-2024-DISEASE-09-01: European Partnership: One Health AntiMicrobial Resistance

• HORIZON-MISS-2024-CANCER-01-01: Use cases for the UNCAN.eu research data platform
• HORIZON-MISS-2024-CANCER-01-02: Support dialogue towards the development of national cancer data nodes
• HORIZON-MISS-2024-CANCER-01-03: Accessible and affordable tests to advance early detection of heritable cancers in European regions
• HORIZON-MISS-2024-CANCER-01-04: Support a pragmatic clinical trial programme by cancer charities
• HORIZON-MISS-2024-CANCER-01-05:Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer
• HORIZON-MISS-2024-CANCER-01-06:HORIZON-MISS-2024-CANCER-01-04:An information portal for the European Cancer Patient Digital Centre

• CP-g-24-10: Call for proposals on the European Hub for vaccine development (HERA)
• CP-g-24-105: Call for proposals to support the development of novel antivirals (HERA)
• CP-g-24-11: Call for proposals for next-generation respiratory protection (HERA)
• CP-g-24-12: Call for proposals to support innovative manufacturing technologies and processes in the Union for medicines production (HERA)